Wordt geladen...
Antivascular Endothelial Growth Factor Antibody for Treatment of Glioblastoma Multiforme
Despite aggressive investigation, glioblastoma multiforme (GBM) remains one of the deadliest cancers, with low progression-free survival and high one-year mortality. Current first-line therapy includes surgery with adjuvant radiation therapy and cytotoxic chemotherapy, but virtually all tumors recur...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
The Permanente Journal
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3854812/ https://ncbi.nlm.nih.gov/pubmed/24361023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7812/TPP/13-081 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|